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Abstract
Background—Explore the use of electronic health records (EHRs) in fetal alcohol syndrome 
(FAS) surveillance systems.
Methods—Using EHRs we identified diagnoses and anthropometric measurements related to the 
FAS criteria developed by the Fetal Alcohol Syndrome Surveillance Network (FASSNet) among 
children aged 0 to 12 years.
Results—There were 143,393 distinct children aged between 0 and 12 years enrolled in Kaiser 
Permanente, Georgia, during the study period. Based on diagnoses and anthropometric 
measurements, 20,101 children met at least one criterion of interest, and when grouped into 
combinations of different criteria there were 2285 who met GROWTH+CNS criteria, 76 children 
who met GROWTH+FACE criteria, 107 children who met CNS+FACE criteria, and 93 children 
who met GROWTH+CNS+FACE criteria. The prevalence of FAS as defined by FASSNet is 1.92 
per 1000 children. We linked 17,084 (85.0%) children to their mothers in the health plan; only 3% 
of mothers of children in the GROWTH+CNS+ FACE group had an indication of alcohol or drugs 
use, but they had the highest rate of depression (39%).
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Conclusion—Data of utility in identification of FAS are readily available in EHRs and may 
serve as a basis for intervention with at-risk children and in planning of future FAS surveillance 
programs.
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Introduction
Prenatal alcohol exposure is the leading preventable cause of birth defects and 
developmental disabilities (American Academy of Pediatrics. Committee on Substance 
Abuse and Committee on Children With Disabilities, 2000). The diverse constellation of 
structural, developmental, and behavioral abnormalities that results from prenatal alcohol 
exposure is referred to as Fetal Alcohol Spectrum Disorders (FASD), the most severe of 
which is Fetal Alcohol Syndrome (FAS) (Barr and Streissguth, 2001; Ebrahim et al., 1998; 
Centers for Disease Control and Prevention, 2002).
The diagnosis of FAS rests on the demonstration of characteristic facial features, prenatal 
and/or postnatal growth deficiency, structural or functional abnormalities of the central 
nervous system (CNS), and a history of prenatal alcohol exposure. Therefore, the most 
effective diagnostic regime involves multidisciplinary assessment. Because of this 
diagnostic approach, the identification of appropriate data sources for surveillance is 
challenging. Given the many challenges of FAS surveillance, it has been suggested that the 
majority of children with FAS remain undetected; thus, current prevalence estimates are 
likely to be underestimates (May et al., 2009).
Previous FAS surveillance systems have varied considerably in their methods. Passive 
surveillance systems collect data from registries or existing records (e.g., birth certificates, 
birth defect registries, and registries of children with developmental disabilities) and use the 
available information to ascertain FAS cases. Although this approach is relatively 
inexpensive, the lack of consistent and complete data and difficulty obtaining relevant 
longitudinal information from different disciplines are major disadvantages. Active case 
ascertainment methods include in-school studies and aggressive searches for children with 
FAS in selected populations or catchment areas (May and Gossage, 2001). While active case 
ascertainment methods are ideal for identifying children with FAS and have generated the 
highest prevalence estimates, they involve interdisciplinary interactions and are expensive, 
time consuming, and labor intensive (May et al., 2009).
Recent evidence-based studies have shown that early, targeted intervention can improve the 
lives of children with FAS (Peadon et al., 2009). Educational and learning strategies were 
evaluated in seven studies and suggest that virtual reality training, cognitive control therapy, 
language and literacy therapy, mathematics intervention, and rehearsal training for memory 
may be beneficial strategies. Three studies suggested that social skills training may improve 
social skills and behavior at home and Attention Process Training may improve attention. 
Pharmacological interventions, evaluated in two studies, showed some benefit from 
stimulant medications. Important lessons emerged from some of these studies that may 
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explain success, such as parent education and training, teaching children specific skills they 
would usually learn by observation or abstraction, and integration into existing systems 
(Bertrand, 2009). With improved methods to identify suspect children, these evidence-based 
interventions can be used to improve the long-term outcomes of children with FAS.
Electronic health records (EHRs) have been used recently to create new surveillance 
systems for chronic kidney disease (Navaneethan et al., 2011), diabetes (Harris et al., 2010), 
melanomas (Eide et al., 2011), and urinary tract infections (Landers et al., 2010). Others 
have compared surveillance based on EHRs with traditional surveillance systems for acute 
hepatitis B (Klompas et al., 2008), acute lung injury (Herasevich et al., 2009), agriculture-
based injuries (Earle-Richardson et al., 2011), incidence of Chlamydia infection 
(Suijkerbuijk et al., 2011), and surgical site infections (Inacio et al., 2011). In contrast, the 
literature on use of EHRs for birth defects is sparse. Bukowinski and colleagues 
(Bukowinski et al., 2008) extracted data on hemangiomas and 21 birth defects from EHRs 
and used the data to investigate associations. The current status of EHR systems in centers 
for adult congenital heart disease has been evaluated recently (Weiss et al., 2011), including 
the level of interest in a uniform system on a national basis toward research and other 
applications.
The goal of the current investigation was to assess the feasibility of developing an FAS 
surveillance system using EHRs available in an integrated health care system. The first 
objective was to search for and extract pertinent data elements from the EHRs database that 
would provide relevant FAS case definition information. The second objective was to 
analyze these data to assess the availability of particular data elements.
Methods
Data Source and Study Population
Kaiser Permanente, Georgia (KPGA), is an integrated health care system that provides 
comprehensive medical care services to approximately 240,000 members in the metropolitan 
Atlanta area (approximately 1.4 million distinct members since 1995). KPGA uses a 
comprehensive medical record system to record all member interactions within the KPGA 
health care system, resulting in extensive health record data including: enrollment history, 
pharmacy dispensing, primary care and specialist encounters, laboratory tests and results, 
emergency department visits, and hospital admissions and discharges. As of mid-2005 all 
KPGA medical office primary care and specialty visits are documented and accessible in an 
EHR.
Fetal Alcohol Syndrome Criteria
For the purpose of assessing the availability of information within EHRs that could be used 
in the surveillance of FAS, we identified elements related to the FAS surveillance criteria 
developed by the Fetal Alcohol Syndrome Surveillance Network (FASSNet), a network of 
states which were funded by the Centers for Disease Control and Prevention to establish or 
enhance population-based surveillance of fetal alcohol syndrome (Hymbaugh et al., 2002). 
These criteria are based on the three following themes:
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1. Facial features (henceforth known as FACE): short palpebral fissures, thin narrow 
upper lip, and smooth philtrum.
2. CNS: (a) structural: head circumference below the 10th centile for age and sex; (b) 
functional: developmental delay, attention-deficit/hyperactivity disorder, and 
intellectual disability.
3. Restricted growth (GROWTH): birth weight or length for gestational age and sex 
and/or postnatal weight or height for age and sex below the 10th centile.
For this study, we used a computerized searching method to identify children having any of 
these criteria and combinations of these criteria. FACE was considered positive even when 
only one of the facial features was present.
Steps to Identify Potential Children With Fas
Step 1—We first identified children enrolled in KPGA at least once (regardless of length of 
enrollment) between January 1, 2006, and September 30, 2012. This cohort was then used in 
all further steps.
Step 2—By using the International Classification of Disease, Ninth Revision, Clinical 
Modification (ICD-9-CM) as shown in Table 1, and/or anthropometric measurements as 
explained further, we identified children aged 0 to 12 at the time of the encounter, with 
information related to any of the FAS criteria. For each anthropometric measurement we 
used national centiles (Centers for Disease Control and Prevention, 2010) for a cutoff of 
<10th centile (for age and sex) as an indication of restricted growth.
Step 3—Children with at least one of the criteria identified in Step 2 were selected for the 
final cohort and grouped into mutually exclusive combinations of FACE only, GROWTH 
only, CNS only, GROWTH+CNS, CNS+FACE, GROWTH+FACE, and GROWTH+CNS
+FACE, where the child required only one of the criteria to be assigned to a particular 
group. For example, a child in the GROWTH+CNS had at least one GROWTH criterion and 
at least one CNS criterion, but no FACE criterion. Based on these groups, we examined 
various characteristics of the children including the age at which the criteria were met, race 
and ethnicity, and their usage of care by a specialty physician or clinic.
Step 4—For the children identified in Step 3, physician progress notes were extracted from 
EHRs in the form of unstructured text and facial features were searched using text string 
searches for common terms/phrases developed as part of the FASSNet abstractor guidelines 
(see Supp. Table A1, which is available online). We performed text string searches for terms 
related to facial features by “process of elimination,” where we first searched for broad 
terms and then narrowed the records down through several iterations of refinement by 
manually looking through the text and eliminating phrases that did not relate to the criteria 
of interest.
Step 5—Using a unique family subscriber identifier, we linked the children identified in 
Step 3 to their mothers' records within the health plan database and searched for any 
indication of tobacco use, alcohol use, drug use, mental diagnoses, or antidepressant use. 
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Because not all of the children identified in Step 3 were born in the KPGA system, we 
decided not to limit the search for these conditions to the pregnancy period, but instead 
searched for them at anytime within the mother's EHR. Any indication of maternal alcohol 
use was identified in two ways: (1) by means of ICD-9-CM codes suggesting alcohol use 
(Table 1); or (2) the physician recorded information about alcohol use in the EHR. The EHR 
has a field labeled “alcohol use (yes/no)” with an accompanying field “alcohol comment.” If 
a mother's record had at least one “yes” indicated in the field “alcohol use (yes/no),” this 
was considered a “yes” even if other EHRs for the mother indicated “no.” A similar method 
was used for the tobacco use field. Due to the inconsistency in the “alcohol use (yes/no)” 
field, we also searched the “alcohol comment” field for any indication of at least daily 
alcohol use. When examining the distinct values in this comment field we found most 
comments were short with minimal complexity. Therefore, we did not perform complex text 
string searches on the alcohol comment field (unlike the unstructured text of the physician 
progress notes when identifying facial features), but rather observed and categorized the 
comments manually.
Statistical Analyses
To assess differences in race, gender, and age across the case-status groups, we used the chi-
square test of independence and analysis of variance. We stratified the analyses by those 
who met only one criterion, and those who met a combination of criteria, and conducted the 
comparisons among the case-status groups within these two larger groups. When examining 
race we collapsed “American Indian,” “Hispanic,” “Asian/Pacific Islander,” and “Other” 
into the category of “Other” due to low numbers.
Results
There were 143,393 distinct children aged between 0 and 12 years (i.e., < 13 years) enrolled 
in KPGA at least once between January 1, 2006, and September 30, 2012. From the 
children's EHRs, we extracted information on anthropometric measurements and diagnoses 
or characteristics of interest. For anthropometric measurements, we extracted 19,648 birth 
weight readings, 14,795 birth length readings, 547,423 postnatal height readings (available 
for 87,093 children), 840,193 postnatal weight readings (available for 92,210 children), and 
205,568 birth and postnatal head circumference readings (available for 37,617 children up to 
the age of 3 years). When we searched for the diagnoses of interest, there were a total of 
600,708 records extracted belonging to 14,570 distinct children and, on average, each child 
had nine distinct encounter dates (range = 1–673) and two distinct ICD-9-CM codes (range 
= 1–16).
As shown in Table 2, 20,101 children met at least one criterion of interest. Among these, 
8616 met at least one of the GROWTH criteria, 13,437 met at least one of the CNS criteria, 
and 702 met at least one of the FACE criteria. Within the GROWTH criteria, the most 
common subcriterion was an indication of “slow fetal growth” (ICD-9-CM 764.x) (n = 
2919) followed by low postnatal weight (n = 2859); within the CNS criteria, the most 
common sub-criterion was small postnatal head circumference (n = 840) for structural 
anomalies, and attention-deficit/hyperactivity disorder (n = 7211) for functional anomalies; 
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within the FACE criteria, the most common subcriterion was anomalies of skull and face 
bones (n = 679).
When grouping the children into mutually exclusive groups based on combinations of 
different criteria, 2285 distinct children met both the GROWTH+CNS criteria, 76 children 
met both the GROWTH+FACE criteria, 107 children met both the CNS+FACE criteria, and 
93 distinct children met the GROWTH+CNS+FACE criteria. Ninety-one of these had a 
FACE diagnosis of ICD-9-CM 756.0 (“Anomalies of skull and face bones”). In addition, we 
identified 12 children who had a 760.71 ICD-9-CM code (“Alcohol-Fetal alcohol 
syndrome”) indicating prenatal alcohol exposure. However, only nine of them were among 
the children selected in the main cohort for having at least one FAS criterion (4 = CNS only, 
5 = CNS+GROWTH). The other three children met no criteria and were excluded from 
further analyses. We also searched for diagnoses of DiGeorge (ICD-9-CM 279.11) and 
Velocardiofacial (ICD-9-CM 758.32) syndromes among all 20,101 children and a total of 13 
had at least one of these conditions, with only two of these children belonging to the 
GROWTH+CNS+-FACE group. These syndromes were not present among children in the 
CNS+FACE or GROWTH+FACE groups.
Table 3 shows selected characteristics of the distinct children who met only one FAS 
criterion or a combination of FAS criteria. The GROWTH+CNS+FACE group had a higher 
percentage of whites (46%) compared with blacks (22%), while there were more blacks in 
the GROWTH+-FACE and FACE only groups. The distributions by sex also differed among 
the single criterion groups, but not among the combination groups. Among the groups that 
met a single criterion, those in the CNS only group were older when they met this criterion 
than the groups who met the growth or face only criteria. Consistent with this result, when 
we compared children with a combination of criteria, those that included the CNS criterion 
in the combination were older regardless of the combination of criteria they had met.
Of children in the main cohort, 18,867 (94%) had physician progress notes available, with a 
total of 931,401 progress notes. These notes were available in all children in the GROWTH
+CNS+FACE group and in at least 92% of the children in each of the other groups. Overall, 
37% of the children had 1 to 20 distinct notes available, 20% had 21 to 40 notes, 13% had 
41 to 60 notes, and the remainder had over 60 notes available. When searching for terms/
phrases related to facial features within the progress notes (Table A1), there were only five 
children with common phrases related to eye abnormalities (esotropia = 4, strabismus = 1), 
but none of these children had an indication of abnormal facial features by means of ICD-9-
CM. In fact, four of them were in the CNS only group and one in the GROWTH+CNS 
group. We did not find any records with text related to thin narrow upper lip, smooth 
philtrum, flattened face, or related anomalies of the nose.
Table 4 shows the characteristics of the mothers we linked to the children in the main 
cohort. We successfully linked 17,084 (85.0%) of the children to their mothers with the 
GROWTH+CNS+FACE group having the highest percentage of linked mothers (94.6%). Of 
those not linked, there were 112 children with no family subscriber identifier and 2947 
enrolled under a male subscriber with no female in the family. There were 27 children that 
had two females listed as the main subscriber and spouse, domestic partner, or spousal 
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equivalent; therefore, there was no way of assigning either one as the mother. For these 
combinations, we searched both females' EHRs for alcohol use and other conditions. Based 
on distinct numbers, there were 496 (2.9%) children with a mother that had an indication of 
alcohol use (“daily” use from a physician comment or a diagnosis). For mental diagnoses, 
depression was highest in each of the groups when compared with other mental diagnoses. 
Overall, the GROWTH+CNS+FACE and CNS ONLY groups had the highest rate of 
smoking, alcohol, depression, and antidepressant use when compared across the groups.
When counting the number of children who had at least one visit to a physician/facility 
listed as “specialist care” in the EHR database, the children in the GROWTH+CNS+FACE 
group had the highest percentage in all selected specialist care categories, except for 
behavioral health, which was highest among the CNS only group (Fig. 1). Among children 
in the GROWTH+CNS+FACE group, the highest percentage of children visiting a specialist 
care physician/facility was for neurology (64%) and ophthalmology (57%).
For the FASSNet surveillance project, children were considered to meet the case status for 
FAS when they met criteria for CNS+FACE or GROWTH+FACE (“probable” case status) 
or for GROWTH+CNS+FACE (“confirmed” case status). Using the 143,393 children once 
enrolled in KPGA between January 1, 2006, and September 30, 2012, as a denominator, the 
prevalence of FAS as defined by FASSNet case status is 1.92 per 1000 children (or 1.91 per 
1000 if we exclude the two children with DiGeorge and Velocardiofacial syndrome).
Discussion
To our knowledge, this is the first study that has explored the use of EHRs in an integrated 
healthcare system as a method of identifying children with possible FAS. Our study shows 
how the extensive information available within the EHRs might eventually be extracted and 
used for FAS surveillance. For example, we were able to identify over 20,000 children 
having at least one finding of interest from over 600,000 records extracted. Among these, 93 
had at least one finding in all three of the areas of interest (i.e., GROWTH, CNS, and 
FACE), whereas 2468 had anomalies in only two areas (GROWTH+CNS, GROWTH
+FACE, or CNS+FACE). When searching physician progress notes for facial features, we 
failed to identify any information pertaining to thin narrow upper lip or smooth philtrum, but 
found five notes related to eye abnormalities. This could be due to one or more of the 
following factors: (1) our text search approach was not sensitive enough to detect the 
phrases of interest; (2) these features are uncommon and, therefore, few positive hits would 
be expected; and (3) these anomalies are more often recorded by trained physicians such as 
dysmorphologists, while the majority of encounters for the children in our cohort were with 
general pediatricians.
While the purpose of this pilot project was not to develop a prevalence estimate for FAS, it 
is worthwhile to compare our estimate to previously reported estimates. Of the 143,393 
children enrolled between January 1, 2006, and September 30, 2012, 276 met the FASSNet 
surveillance case criteria for FAS, resulting in a FAS prevalence of 1.92 per 1000 children. 
This prevalence estimate is within the range of reported FAS birth prevalence in the U.S. 
general population using varying surveillance methods (Cordero et al., 1994; May and 
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Gossage, 2001; May et al., 2009). Prevalence for FAS in the reported studies ranged from 
0.1 per 1000 births in metropolitan Atlanta (1981–89) to 2.0 per 1000 births in North Dakota 
(1991–94). The KPGA prevalence is a little higher than those reported for FASSNet, which, 
for birth years 1995 to 1999, ranged between 0.30 and 1.50 per 1000 births among four 
surveillance sites (CDC, 2002; Meaney and Miller, 2003). It is of interest to note that in 
FASSNet, the criteria for facial features was a diagnosis of abnormal facial features reported 
by qualified examiners or at least two of the facial features of a thin narrow upper lip, short 
palpebral fissures, or smooth philtrum, whereas in our study, the majority of children with 
FACE were ascertained by means of a nonspecific ICD-9-CM code.
It is logical to assume that manual abstraction and review of these EHR records is probably 
the most accurate method for identifying facial features related to FAS. However, to 
implement surveillance on a large population using this method would be time consuming 
and expensive. For this reason, searching the physician progress notes is preferable and 
should be further developed using natural language processing (NLP). Multiple studies have 
used NLP to examine various outcomes in physician progress notes within EHRs (Love et 
al., 2011; Murff et al., 2011; Hou et al., 2012) and the literature on this subject continues to 
grow. To improve the success of NLP for FAS, education of family practitioners and 
pediatricians as well as neurologists, ophthalmologists, and other specialists would be 
necessary to improve recognition and documentation of FAS facial features.
A potential problem with EHR-based FAS surveillance using computerized searching 
methods across large databases is the misclassification of children with other developmental 
disabilities or congenital anomalies as FAS (i.e., false-positives). However, with further 
development of robust methods, this misclassification would likely be minimal compared 
with the numerous advantages of applying an automated computerized searching method 
across large populations to identify children potentially with FAS who would benefit by 
evidence-based interventions at an earlier age. Because the facial features of FAS have been 
reported to be present in several other syndromes including, but not limited to, DiGeorge, 
Velocardiofacial; using ICD-9-CM codes, we searched for these syndromes and among the 
276 children with probable FAS only two children were identified, both with DiGeorge and 
Velocardiofacial syndrome. This does not negate the possibility that other children in the 
group with potential FAS may have this or other as yet undiagnosed syndromes.
When examining maternal alcohol use during pregnancy and other maternal factors, we 
faced three main challenges. First, linking the mother to the child within health plan data 
may not be totally accurate when based solely on a family subscriber identifier, because we 
cannot be certain that we have identified the biologic mother as there were only 5473 (27%) 
of the children in our final cohort actually born within the Kaiser Permanente health care 
system. Therefore, the individual may be a legal guardian or adoptive parent, albeit these 
numbers would be small. Second, it is not possible to understand if the maternal alcohol use 
occurred during pregnancy of the identified child. Third, it is not possible to determine the 
reliability of information pertaining to alcohol use, particularly when self-reported by the 
patient to the physician. This circumstance, however, applies to all surveillance systems 
investigating alcohol use. In our study, we identified only a small number of women with 
alcohol and/or drug use, and it is interesting that the patterns for alcohol and drug use were 
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similar across the mutually exclusive groups of children, which may provide validation on 
the accuracy of this information. It is well known that mothers underreport alcohol during 
pregnancy (Morrow-Tlucak et al., 1989; Strandberg-Larsen et al., 2006; Bhuvaneswar et al., 
2007), thus limiting the use of this information in the surveillance of FAS. Another approach 
to overcoming the limitations of self-reported maternal alcohol use is to identify mental 
health conditions that may be associated with alcohol use. Despite the low number of 
mothers of children in the GROWTH+CNS+FACE group having any indication of alcohol 
or drug use, it was interesting to find that these mothers had the highest rate of depression 
and antidepressant use compared with all other groups. The link between alcohol use and 
depression is well established (Dixit and Crum, 2000; Littlejohn, 2005; Leis et al., 2012; 
Vythilingum et al., 2012). The stigma associated with alcohol use during pregnancy is likely 
to result in underreporting, which would not be the case for depression during pregnancy. 
Our findings beg the question of whether maternal depression could serve as a proxy for 
alcohol use during pregnancy. It is important to note, however, that the higher rate of 
depression may be associated with the challenges of caring for a child with FAS or mental/
social disabilities.
One of the problems of tracking potential FAS cases in any healthcare records system is the 
lack of a gold standard for identification of FAS, such as an ICD-9 code specific to FAS that 
could be applied in the search or a laboratory test that identifies individuals with the 
condition. This problem also limits our ability to evaluate easily the individuals identified 
with potential FAS through EHR records with respect to a diagnostic code or positive lab 
test. This limitation creates the need for another method of evaluating the individuals we 
identified, such as independent abstraction of the hard copy medical records. It was not 
possible to conduct medical record abstractions in the current study, but this will be required 
for future investigations. This situation may improve with implementation of the ICD-10 
coding system which does include a code specific for FAS with facial dysmorphology.
The surveillance of FAS is further complicated by the fact that the various diagnostic criteria 
are not all evident simultaneously either at birth or in childhood and, consequently, 
surveillance of children with potential FAS requires continuous follow up. If not evident at 
birth, growth restriction is usually evident within the first few years of life, and given that 
height and weight are measured at each physician encounter, restricted growth could be 
identified reasonably early using EHRs. On the other hand, facial features, and particularly 
functional CNS disabilities, may require a longer time period to become more evident or be 
diagnosed. This was demonstrated in these data when we found that children that met CNS 
criterion, whether singly or in combination with other criteria were older when they met any 
of the criteria, suggesting the influence of school-age testing for CNS involvement. For this 
reason, a major advantage of using EHRs for FAS surveillance is not only the ability to take 
a snap-shot in time of all the information required to capture potential FAS cases, but also to 
follow children over time and capture the criteria in a timely manner as they evolve. Using 
an automated computer searching method on updated data would allow the surveillance of 
FAS to be extremely timely with children being captured as early as the information in the 
administrative data is updated (which is usually daily). Furthermore, computer searching 
methods such as ours could improve outcomes for children and mothers by incorporating 
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built-in EHR communication to alert providers. An integrated healthcare system such as 
Kaiser Permanente could serve as a model on how to use EHRs to improve health outcomes.
Conclusions
Our research shows that there is much information available within EHRs that can be 
accessed to enhance current surveillance of FAS. However, these methods may not 
overcome obstacles such as the reticence of physicians to make the diagnosis of FAS, 
because of the social stigma it may imply, or the deficiencies in clinical recognition of minor 
anomalies that serve as clues for its diagnosis. Nevertheless, this approach may help identify 
some children at risk who would benefit from evidence-based interventions which are now 
becoming available. The use of EHRs and automated data extraction processes in the 
surveillance of FAS has yet to be explored thoroughly and warrants further attention as the 
use of these methods allows for low cost and less labor intensive procedures, as well as up-
to-date data extractions and the longitudinal follow-up of children with FAS.
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Table 1
ICD-9-CMa Codes and Anthropometric Measurements Used for Potentially Identifying 
Children with Fetal Alcohol Syndrome (FAS)
Criteria ICD-9-CM CODE/anthropometric measurement
FACE
Anomalies of the skull and face bones 756.0
Other specified congenital anomalies of eyelid 743.63
Anomalies of the nose 748.1
Major anomalies of the jaw size 524.0
CNSb
Small head circ. (birth, postnatal) < 10th % ile for gender and age
Microcephaly 742.1
Congenital reduction of brain 742.2
Developmental delay
 Motor skills disorders 315.4,315.8,315.5
 Communication disorders 315.31,315.32,315.35,315.39,307.0,307.9
 Learning disorders 315.00,315.01, 315.02, 315.1, 315.2, 315.9
 Pervasive develop. Disorders 299.00,299.8
Attention deficit disorder of childhood 314.0,314.00,314.01,314.9
 Conduct disorders 312.8,312.81,313.81,312.9
Intellectual disability
 Mental retardation 317,318.0,318.1,318.2,319
GROWTH
Slow fetal growth and fetal malnutrition 764
Light-for-dates infant w/o mention of fetal 
malnutrition
764.0,764.00 – 09,764.1,764.10 – 19
Fetal malnutrition without mention of light-for-dates 764.2,764.20 – 29
Fetal growth retardation unspecified 764.9
Lack of physical level in childhood 783.4,783.40,783.41,783.42
Small birth weight < 10th % ile for gender and age
Small postnatal weight < 10th % ile for gender and age
Small birth length < 10th % ile for gender and age
Small height < 10th % ile for gender and age
FAS




Alcohol induced mental disorders 291.0–5, 291.8,291.81,291.82,291.89,291.9
Alcohol dependence syndrome 303,303.0,303.00–03, 303.9,303.90–93,
Nondependent alcohol abuse 305.0,305.00,305.01–03













Hansen et al. Page 15




Alcoholic fatty liver 571.0–3
Excessive blood level of alcohol 790.3
Toxic effect of ethyl alcohol 980.0–2, 980.8,980.9
Personal history of alcoholism V11.3
Alcoholism in family V61.41
Screening for alcoholism V79.1
Maternal drug use
Amphetamines 304.4, 304.40–43, 305.7, 305.7–73
Cannabis 304.3,304.30–33, 305.2, 305.20–23
Cocaine 304.2, 304.20–23, 305.6, 306.60–63, 970.81









ICD-9-CM, The International Classification of Diseases, Ninth Revision, Clinical Modification.
b
CNS, central nervous system.
c
Attention Deficit Hyperactivity Disorder.
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